Verve Therapeutics
VERV
#6558
Rank
NZ$0.91 B
Marketcap
$10.82
Share price
-0.16%
Change (1 day)
-31.43%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$5.20

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.35. In 2022 the company made an earnings per share (EPS) of -$4.93 a decrease over its 2021 EPS that were of -$4.27.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.205.59%
2022-$4.9315.54%
2021-$4.2761.32%
2020-$2.64